Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway
about
Recycling Endosomes and Viral InfectionExpression of mutant or cytosolic PrP in transgenic mice and cells is not associated with endoplasmic reticulum stress or proteasome dysfunctionMutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 SubunitCell type-specific neuroprotective activity of untranslocated prion protein.Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.Prion infection impairs lysosomal degradation capacity by interfering with rab7 membrane attachment in neuronal cellsMutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosisSynaptic dysfunction in prion diseases: a trafficking problem?Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases.Prions disturb post-Golgi trafficking of membrane proteins.Lysosomal Quality Control in Prion Diseases.The hydrophobic core region governs mutant prion protein aggregation and intracellular retention.Disturbed vesicular trafficking of membrane proteins in prion disease.Quantitative proteomic analysis reveals the neuroprotective effects of huperzine A for amyloid beta treated neuroblastoma N2a cells.
P2860
Q26752566-62A33707-867D-4B08-BCB9-8609CDBD4DD2Q28477995-ABA24524-873D-4767-97AE-5D72DD0CDF96Q28508384-022F9277-AAF9-408B-AB42-84662CE7D0A8Q33742065-36D81974-D52D-4C26-B375-645F3A6A6C8FQ35448997-BB313337-8933-4F90-B77D-4A3D733880C8Q35714147-CFA79D33-B4AE-4C9B-AB35-9E0306CA3F10Q36569559-582AA788-C0ED-4347-91F4-8C37ED9DF483Q36890607-FD113407-5BF2-4FB1-9A34-C10BFC63089FQ37393121-806C4E96-653E-4394-8741-F610B74731AEQ39015438-34AEFDDB-62AF-459F-B0A6-7CA83FDE20C8Q39152094-FE171625-0B8C-4DC5-8E68-8A1B7210D974Q39250023-2C0B9B04-0585-4352-B5FD-2C88097AB756Q39680946-D968E43C-3A31-40FC-B8CC-25F02C7D9593Q42949799-E56EB070-DC33-4DE5-8B3E-51445D86EA2BQ45917550-F3DDE050-CE2D-481E-B95E-37269025FD79
P2860
Mutant prion protein expression is associated with an alteration of the Rab GDP dissociation inhibitor alpha (GDI)/Rab11 pathway
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@ast
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@en
type
label
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@ast
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@en
prefLabel
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@ast
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@en
P2093
P2860
P50
P1476
Mutant prion protein expressio ...... itor alpha (GDI)/Rab11 pathway
@en
P2093
Luana Fioriti
Mauro Pignataro
Tania Massignan
P2860
P304
P356
10.1074/MCP.M900271-MCP200
P50
P577
2009-12-07T00:00:00Z